These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25099849)

  • 1. Ehlers-Danlos syndrome - a commonly misunderstood group of conditions.
    Sobey G
    Clin Med (Lond); 2014 Aug; 14(4):432-6. PubMed ID: 25099849
    [No Abstract]   [Full Text] [Related]  

  • 2. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
    Forghani I
    Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Up-to-date classification and multidisciplinary symptoms of Ehlers-Danlos syndromes].
    Ralovich FV; Kiss N; Horváth K; Kárpáti S; Medvecz M
    Orv Hetil; 2019 Apr; 160(16):603-612. PubMed ID: 30983397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ehlers-Danlos syndrome--a historical review.
    Parapia LA; Jackson C
    Br J Haematol; 2008 Apr; 141(1):32-5. PubMed ID: 18324963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ehlers-Danlos syndrome type I. Ultrastructural study].
    Paradisi M; Giubilei L; Canzona F; Angelo C; Onetti Muda A; Puddu P
    Minerva Pediatr; 1997 May; 49(5):215-9. PubMed ID: 9340484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
    Tinkle BT; Levy HP
    Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable collagen disorders: the paradigm of the Ehlers-Danlos syndrome.
    Byers PH; Murray ML
    J Invest Dermatol; 2012 Nov; 132(E1):E6-11. PubMed ID: 23154631
    [No Abstract]   [Full Text] [Related]  

  • 8. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).
    Beighton P; De Paepe A; Steinmann B; Tsipouras P; Wenstrup RJ
    Am J Med Genet; 1998 Apr; 77(1):31-7. PubMed ID: 9557891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ehlers-Danlos syndrome--diagnosis and subclassification].
    Rand-Hendriksen S; Wekre LL; Paus B
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1903-7. PubMed ID: 16915311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
    Micale L; Fusco C; Castori M
    Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Ehlers-Danlos syndrome].
    Bonzano L; Galligani L; Delmastro PF; Vittone L
    Minerva Med; 1977 Apr; 68(18):1193-8. PubMed ID: 859691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetics of the Ehlers-Danlos syndrome.
    Burrows NP
    Clin Exp Dermatol; 1999 Mar; 24(2):99-106. PubMed ID: 10233664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
    Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
    Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular aspects of the Ehlers-Danlos Syndromes.
    Malfait F
    Matrix Biol; 2018 Oct; 71-72():380-395. PubMed ID: 29709596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ehlers-Danlos syndromes, rare types.
    Brady AF; Demirdas S; Fournel-Gigleux S; Ghali N; Giunta C; Kapferer-Seebacher I; Kosho T; Mendoza-Londono R; Pope MF; Rohrbach M; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Zschocke J; Malfait F
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):70-115. PubMed ID: 28306225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ehlers-Danlos syndrome: clinic and genetic aspects and molecular basis].
    Lapière CM
    Rev Prat; 1988 Feb; 38(6):357-64. PubMed ID: 3353665
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on the new classification of Ehlers-Danlos syndrome and review of the causes of bleeding in this population.
    Jesudas R; Chaudhury A; Laukaitis CM
    Haemophilia; 2019 Jul; 25(4):558-566. PubMed ID: 31329366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ehlers-Danlos syndrome type VIII.
    Nelson DL; King RA
    J Am Acad Dermatol; 1981 Sep; 5(3):297-303. PubMed ID: 7263975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.